Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year |
Award Type |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2016 | R43 | CA203647 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | Complete |
| 2000 | R43 | CA081787 | PAR-99-101 | BUTT, TAUSEEF R. | LIFESENSORS, INC. | LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER | Complete |
| 2002 | R43 | CA096056 | PAR-01-105 | STRAUME, TORE | GENMETRIX, LLC | ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES | Complete |
| 1999 | R43 | CA081903 | PAR-98-066 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD | Complete |
| 2001 | R43 | CA093155 | PAR-99-101 | JOHNSON, PAUL H | EPIGENX PHARMACEUTICALS | WHOLE GENOME METHYLATION ASSAY | Complete |
| 2004 | R43 | CA105542 | PAR-01-105 | PARIS, MARK J | VACCINEX, INC. | FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS | Complete |
| 2016 | R43 | CA203681 | PAR-13-327 | KING, JEFFREY S | VIROGENOMICS BIODEVELOPMENT, INC. | Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia | Complete |
| 2000 | R43 | CA084678 | PAR-98-066 | BAMDAD, CYNTHIA C. | MINERVA BIOTECHNOLOGIES CORPORATION | RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS | Complete |
| 2002 | R43 | CA096059 | PAR-01-105 | LOGE, GARY | SPECTRUMEDIX CORPORATION | AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM | Complete |
| 1999 | R43 | CA081949 | PAR-98-066 | OLINER, JONATHAN D | AFFYMETRIX, INC. | REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS | Complete |
| 2001 | R43 | HL069675 | PAR-99-101 | WILLETT, CATHERINE E | PHYLONIX PHARMACEUTICALS, INC. | ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS | Complete |
| 2004 | R43 | CA107764 | PAR-01-105 | VYKOUKAL, JODY V | ADEPTAS, INC. | RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY | Complete |
| 2016 | R44 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | Next-Generation Antibody Discovery and Development Technology | Complete |
| 2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
| 2001 | R44 | CA081952 | PAR-99-101 | CHEE, MARK S. | ILLUMINA, INC. | RANDOM ARRAYS FOR GENE EXPRESSION PROFILING | Complete |
| 2004 | R44 | CA081903 | PAR-01-106 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS | Complete |
| 2001 | R44 | CA081965 | PAR-99-101 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
| 2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
| 2001 | R44 | CA083396 | PAR-99-101 | GITE, SADANAND | AMBERGEN, INC | NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION | Complete |
| 2004 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
| 2009 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
| 2009 | R44 | CA115041 | RFA-CA-08-013 | ZOU, NIANXIANG | BIO-QUICK CORPORATION | DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE | Complete |
| 2001 | R44 | CA083598 | PAR-99-101 | RAO, CHANDRA | IMMUNICON CORPORATION | ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE | Complete |
| 2004 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
| 2003 | R44 | CA084804 | PAR-01-104 | GOLOVLEV, VAL V | SCI-TEC, INC. | MAGNETICALLY READABLE MICROARRAY | Complete |
| 2009 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
| 2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
| 2001 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
| 2004 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
| 2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
| 2009 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
| 2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
| 2003 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
| 2009 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
| 2007 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
| 2014 | R44 | CA161965 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS | Complete |
| 2003 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
| 2009 | R44 | CA118785 | RFA-CA-06-006 | SCHWARZBACH, ANNA | ASURAGEN, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
| 2007 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
| 2010 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | TWIN LIGHTS BIOSCIENCE, INC. | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
| 2003 | R44 | CA083390 | PAR-01-105 | WIKTOR, PETER J. | ENGINEERING ARTS | PIEZOELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS | Complete |
| 2002 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
| 2010 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
| 2017 | R44 | CA188154 | PAR-13-327 | PREMSRIRUT, PREM KHOVABUTR | MIRIMUS, INC. | Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research | Complete |
| 2003 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
| 2013 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | QUANTERIX CORPORATION | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
| 2002 | R44 | CA094419 | PAR-99-101 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | LIGHT-UP PNA ARRAYS | Complete |
| 2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
| 2000 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
| 2002 | R44 | CA081835 | PAR-01-105 | DREES, BETH E | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |